Comment on: "Tumour-agnostic drugs in paediatric cancers", Chisholm et al., BJC 2020

Br J Cancer. 2021 Jan;124(2):524-526. doi: 10.1038/s41416-020-01103-0. Epub 2020 Oct 1.

Thomas Richard William Oliver^{1

2}, Thomas John Jackson^{3

4}, Olumide Ogunbiyi³, Neil Sebire^{3

4}, Olga Slater³, Mette Jorgensen⁵, Sam Behjati^{6

7

8}

¹ Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
² Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
³ Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
⁴ UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK.
⁵ Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK. mette.jorgensen@gosh.nhs.uk.
⁶ Wellcome Sanger Institute, Hinxton, CB10 1SA, UK. sb31@sanger.ac.uk.
⁷ Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. sb31@sanger.ac.uk.
⁸ Department of Paediatrics, University of Cambridge, Cambridge, CB2 0QQ, UK. sb31@sanger.ac.uk.

No abstract available

Publication types